US 11787796
Plasma Kallikrein inhibitors and uses thereof
granted A61PA61P29/00A61P9/00
Quick answer
US patent 11787796 (Plasma Kallikrein inhibitors and uses thereof) held by Takeda Pharmaceutical Company Limited expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P29/00, A61P9/00